Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

Adolescents and adults with eosinophilic esophagitis improved with dupilumab regardless of whether they were practicing food ...

Treatment for eosinophilic esophagitis often involves collaboration between specialists, but patients face challenges in ...

About 1 in 700 people in the U.S. have eosinophilic esophagitis (EoE). There has been a continuous increase in EoE prevalence ...

Researchers from Revolo Biotherapeutics Ltd. recently presented preclinical data for IRL-201104, a clinical-stage ...

EoE is an inflammatory-mediated disease in which white blood cells migrate into and become trapped in the esophagus, creating ...

Eupraxia Pharmaceuticals (EPRX) announced additional positive clinical data from its ongoing RESOLVE Phase 1b/2a trial evaluating EP-104GI for ...

Following results that have sent the stock northward, Research Capital analyst Andre Uddin remains bullish on Eupraxia ...

EoE is an inflammatory-mediated disease in which white blood cells migrate into and become trapped in the esophagus, creating pain and difficulty with swallowing food. The Company's ongoing ...

Eupraxia Pharmaceuticals shares rose in premarket trading Tuesday after the company said it received positive data from its eosinophilic esophagitis treatment trials. Shares traded nearly 6.3% higher ...